文献速递骨质疏松与代谢性骨病创伤骨科

丹麦DXA扫描与非扫描人群的人口学与临床差异

Demographic and clinical differences between individuals with and without DXA scans in Denmark.
PubMed 文献 · Osteoporos Int · 2026-09-26

基于丹麦两个登记队列的横断面研究比较了接受与未接受DXA扫描者的特征。DXA受检者年龄更大、女性更多、合并症和用药负担更重,但既往重大骨折或使用全身性糖皮质激素者中仍有相当比例从未接受DXA。结论认为丹麦DXA使用日益针对高骨折风险人群,但二级预防仍存在显著缺口。

要点

  • DXA受检者年龄更大、女性更多,合并症、既往骨折及中枢作用、心血管和抗骨质疏松药物使用负担更重。
  • 上述差异在2011–2021年比2000–2010年更明显。
  • 相当比例的重大骨折患者或全身性糖皮质激素使用者从未接受过DXA。

核心结论

  • 丹麦DXA使用日益针对高骨折风险个体,但二级骨折预防仍存在显著缺口。
  • 改进高风险患者尤其是重大骨折患者的识别与评估仍至关重要。

研究设计与样本

  • 全国性横断面研究,使用两个丹麦登记队列:骨折个体和糖尿病个体,各匹配无相应疾病的对照。
  • 纳入2000至2021年间首次DXA扫描的≥50岁个体,与按性别和出生年匹配的无DXA记录个体比较。
  • 共纳入两个数据库中有DXA记录的379,686人和348,980人,无DXA记录的1,571,452人和1,736,828人。
  • 使用描述性统计和标准化均值差进行总体及跨时间段(2000–2010与2011–2021)比较。

主要发现

  • DXA受检者年龄更大、女性更多,合并症负担、既往骨折及中枢作用、心血管和抗骨质疏松药物使用均更多。
  • 这些差异在2011–2021年比2000–2010年更明显。
  • 相当比例的重大骨折个体或全身性糖皮质激素使用者从未接受过DXA。

临床怎么用

  • 提示骨科智能体应关注重大骨折后及长期使用全身性糖皮质激素患者是否已接受DXA评估。
  • 对高骨折风险但尚未行DXA者,应主动识别并推动骨密度评估以弥补二级预防缺口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This study utilized two Danish registry-based cohorts to compare characteristics of DXA scanned individuals with not DXA scanned individuals. DXA scanned individuals had more comorbidities and used more medications, but there were signs of insufficient DXA scanning, particularly regarding prior major fractures and systemic glucocorticoid use. BACKGROUND: Osteoporosis is increasingly prevalent, yet many high-risk individuals remain undiagnosed and unscanned with dual-energy X-ray absorptiometry (DXA). We aimed to describe DXA use in Denmark, focusing on characteristics, comorbidities, and medication use among scanned versus non-scanned individuals, and to assess changes over time by comparing 2000-2010 with 2011-2021. METHODS: We conducted a nationwide cross-sectional study using two Danish registry-based cohorts: individuals with fractures and individuals with diabetes, each matched to controls without these conditions. Individuals aged ≥50 years with a first DXA scan between 2000 and 2021 were identified and compared with sex- and birth year-matched individuals without a recorded DXA scan regarding comorbidities, prior fractures, lifestyle-related risk proxies, and medication use. Descriptive statistics and standardized mean differences were used overall and across time periods. RESULTS: We included 379,686 and 348,980 individuals with a recorded DXA and 1,571,452 and 1,736,828 individuals without a DXA from the two databases. DXA recipients were older, more often female, and had a greater burden of comorbidities, prior fractures, and use of centrally acting, cardiovascular, and anti-osteoporotic medications. These differences were more pronounced in 2011-2021. Nevertheless, a substantial proportion of individuals with major fractures or users of systemic glucocorticoids had never undergone DXA. CONCLUSION: DXA utilization in Denmark increasingly targets individuals at high fracture risk, yet significant gaps persist in secondary fracture prevention. Improved identification and assessment of high-risk patients - particularly those with major fractures - remain essential.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Andersen SS, Kvist AV, Madsen MD, et al. Demographic and clinical differences between individuals with and without DXA scans in Denmark. Osteoporos Int. 2026. PMID: 42799873. doi:10.1007/s00198-026-08222-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。